Skip to main content
Clinical Trials/NCT03580642
NCT03580642UnknownNot Applicable

Efficacy and Usability of eHealth Technologies in Stroke Survivors for Prevention of a New Stroke and Improvement of Self-management: Phase III Randomized Control Trial

Biocruces Bizkaia Health Research Institute2 sites in 1 country40 target enrollmentStarted: April 27, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
40
Locations
2
Primary Endpoint
System Usability Scale

Study Overview

Brief Summary

The aim of the study is to evaluate the usability of the system and its accordance with the users' needs. This evaluation will consider the effectiveness and the efficiency of the system, as well as stroke survivors' satisfaction. The effectiveness and the efficiency of the system will be measured by:

  • The relationship between the control of stroke survivors' daily activities and their risk of having a secondary stroke,
  • The decrease of the need for caregivers,
  • And consequently an improvement in stroke survivors' self-management.

Detailed Description

The aim of the study is to evaluate the usability of the system and its accordance with the users' needs. This evaluation will consider the effectiveness and the efficiency of the system, as well as stroke survivors' satisfaction.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18 to 80 years.
  • First ischemic stroke within the past 6 months.
  • Hemiparesia with mild (91-99)-moderate (61-90) disability (Barthel Index).
  • With or without speech patology but able to understand simple orders ( >45).
  • Able to cope and to understand the guidelines to use the devices.
  • Informed consent signed.

Exclusion Criteria

  • Life expectancy <12 months.
  • Severe cognitive impairments.
  • Medical comorbidities that could interfere with the home-rehabilitation program (MoCA < 26).
  • Socio-familiar dystocia (SFES ≥ 14).
  • Modified Rankin Scale > 1.

Arms & Interventions

eHealth Technologies

Experimental

eHealth Technologies is a messure of diferent paramenters of the patient; heart rate, blood pressure, weight, thermometer, daily activity.

Intervention: eHealth Technologies (Device)

Control

No Intervention

Habitual treatment.

Outcomes

Primary Outcomes

System Usability Scale

Time Frame: 12 months

The System Usability Scale (SUS) provides a "quick and dirty", reliable tool for measuring the usability. Developers work to create systems that are easy and straight-forward for people to use. Terms such as "user friendly" and "easy-to-use" often indicate these characteristics, but the overall technical name for them is usability.

Secondary Outcomes

  • Physical Activity(12 months)
  • Line Bisection Test(12 months)
  • Health Literacy Test(12 months)
  • Age(12 months)
  • Oxfordshire Community Stroke Project Classification(12 months)
  • Gijon's social-familial evaluation Scale(12 months)
  • Ethnic group(12 months)
  • Type of profession(12 months)
  • MAST Test(12 months)
  • Functional Ambulation Categories(12 months)
  • 6 Minutes Walking Test(12 months)
  • Disphagia(12 months)
  • Stroke date(12 months)
  • Modified Barthel Index(12 months)
  • Mississippi Aphasia Screening Test(12 months)
  • Montreal Cognitive Assessment(12 months)
  • Gender(12 months)
  • Hand dominance(12 months)
  • Education level(12 months)
  • Fatigue Severity Scale(12 months)
  • Total Cholesterol(12 months)
  • LDL(12 months)
  • Albumin(12 months)
  • Charlson Comorbidity Index(12 months)
  • Deprivation index(12 months)
  • Berg Balance Scale(12 months)
  • Frenchay Arm Test(12 months)
  • Asworth Modified Scale(12 months)
  • Analogic Visual Scale(12 months)
  • Analgesic Treatments(12 months)
  • Glycaemia(12 months)
  • Mediterranean Diet Assessment Test(12 months)
  • Hobbies(12 months)
  • Medical Research Council Scale(12 months)
  • MoCA Test(12 months)
  • 10 Meters Walking Test(12 months)
  • Golberg Scale(12 months)
  • Weight(12 months)
  • Height(12 months)
  • BMI(12 months)
  • Waist to Hip Ratio(12 months)
  • Blood Pressure(12 months)
  • Campimetry(12 months)
  • Heart Rate(12 months)
  • Proteins(12 months)
  • Apoportein A1(12 months)
  • Lawton Index(12 months)
  • SF-36(12 months)
  • Pharmacological Accountability(12 months)
  • Waist Size(12 months)
  • Toxic Consumption(12 months)
  • HDL(12 months)
  • SIS(12 months)
  • Number of Readmissions(12 months)
  • HbA1c(12 months)
  • Apoprotein B(12 months)
  • Stroke Self Management Questionary(12 months)
  • Post Stroke Checklist(12 months)
  • Non Pharmacological Accountability(12 months)
  • Stroke Management Questionary(12 months)
  • Satisfaction Questionary(12 months)
  • Stroke Recurrences(12 months)

Investigators

Sponsor
Biocruces Bizkaia Health Research Institute
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Leire Ortiz Fernández

Principal Investigator

Biocruces Bizkaia Health Research Institute

Study Sites (2)

Loading locations...

Similar Trials